Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Isaac Teitelbaum

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
55
2024
95
13.740
 Why?
Kidney Failure, Chronic
41
2023
546
7.420
 Why?
Peritonitis
21
2024
81
3.820
 Why?
Renal Dialysis
18
2022
423
2.460
 Why?
Dialysis Solutions
11
2023
22
1.800
 Why?
Kidney
8
2023
1385
1.170
 Why?
Peritoneum
6
2023
41
1.170
 Why?
Serum Albumin
3
2022
148
0.890
 Why?
Kidney Tubules, Collecting
12
1994
30
0.890
 Why?
Catheters, Indwelling
5
2019
80
0.730
 Why?
Peritoneal Dialysis, Continuous Ambulatory
6
2021
15
0.730
 Why?
Acute Kidney Injury
5
2023
790
0.680
 Why?
Staphylococcus capitis
1
2019
1
0.660
 Why?
Coagulase
1
2019
6
0.660
 Why?
Renal Insufficiency, Chronic
3
2015
566
0.650
 Why?
Renal Replacement Therapy
4
2023
87
0.630
 Why?
Catheter-Related Infections
1
2019
72
0.620
 Why?
Ferric Compounds
2
2022
46
0.610
 Why?
Sucrose
2
2022
99
0.610
 Why?
Quality of Health Care
2
2020
602
0.610
 Why?
Anti-Bacterial Agents
6
2024
1708
0.580
 Why?
Arginine Vasopressin
7
1997
42
0.570
 Why?
Kidney Transplantation
3
2012
671
0.570
 Why?
Hyperphosphatemia
3
2022
15
0.570
 Why?
Peritoneal Fibrosis
1
2017
1
0.550
 Why?
Humans
77
2024
129266
0.540
 Why?
Staphylococcal Infections
3
2019
389
0.540
 Why?
Kidney Function Tests
4
2020
152
0.520
 Why?
Uremia
2
2014
14
0.520
 Why?
Glucans
2
2015
34
0.510
 Why?
Patient-Centered Care
1
2020
505
0.490
 Why?
Therapeutics
1
2015
14
0.470
 Why?
Body Water
1
2015
20
0.470
 Why?
Kidney Medulla
10
1997
34
0.470
 Why?
Voriconazole
1
2015
20
0.470
 Why?
beta-Cyclodextrins
1
2015
27
0.470
 Why?
Phosphates
2
2022
179
0.450
 Why?
Catheterization
3
2016
174
0.450
 Why?
Antifungal Agents
1
2015
129
0.450
 Why?
Chelating Agents
1
2014
68
0.430
 Why?
Blood Pressure
1
2020
1736
0.410
 Why?
GTP-Binding Proteins
6
1995
158
0.400
 Why?
Hemodialysis Solutions
1
2012
3
0.400
 Why?
Type C Phospholipases
6
1992
72
0.400
 Why?
Acidosis
1
2013
89
0.380
 Why?
Kidney Diseases
4
2021
382
0.380
 Why?
Hemofiltration
2
2010
30
0.360
 Why?
Glucose
2
2015
1001
0.350
 Why?
Hirudins
1
2010
52
0.340
 Why?
Urea
4
2021
76
0.330
 Why?
Cyclic AMP
6
1995
237
0.320
 Why?
Creatinine
5
2020
491
0.320
 Why?
Protein Kinase C
5
1995
260
0.310
 Why?
Kidney Tubules
4
1990
114
0.310
 Why?
Heparin
1
2010
253
0.310
 Why?
Nutritional Status
4
2022
328
0.310
 Why?
Heart Diseases
1
2012
350
0.300
 Why?
Glomerular Filtration Rate
5
2023
711
0.300
 Why?
Drug Resistance, Bacterial
1
2009
175
0.290
 Why?
Hemodialysis, Home
4
2023
8
0.280
 Why?
Survivors
1
2010
457
0.260
 Why?
Peptide Fragments
1
2010
692
0.260
 Why?
Cardiac Surgical Procedures
1
2012
499
0.260
 Why?
Patient Selection
2
2020
662
0.250
 Why?
Postoperative Complications
3
2012
2473
0.250
 Why?
Scleroderma, Systemic
1
2007
114
0.250
 Why?
Calcium
4
2020
1212
0.250
 Why?
Hernia, Abdominal
1
2005
7
0.250
 Why?
Peritoneal Cavity
1
2005
31
0.240
 Why?
Prospective Studies
11
2023
7123
0.240
 Why?
Patient Participation
2
2020
414
0.240
 Why?
Phosphorus
3
2022
92
0.230
 Why?
Time Factors
6
2015
6543
0.230
 Why?
Liver Failure
1
2005
91
0.230
 Why?
Hemoglobins
2
2020
339
0.230
 Why?
Internationality
3
2020
149
0.230
 Why?
Liver Transplantation
2
2012
831
0.220
 Why?
Middle Aged
18
2023
31090
0.220
 Why?
Teicoplanin
1
2024
15
0.220
 Why?
Quality Improvement
2
2023
1095
0.220
 Why?
Quality of Life
5
2020
2687
0.210
 Why?
Blood Chemical Analysis
1
2003
96
0.210
 Why?
Practice Guidelines as Topic
3
2020
1497
0.200
 Why?
Device Removal
2
2019
136
0.200
 Why?
Phosphatidylinositols
3
1991
57
0.190
 Why?
Rats
13
2014
5482
0.190
 Why?
Contraindications, Procedure
1
2021
11
0.190
 Why?
Attitude of Health Personnel
2
2020
1094
0.190
 Why?
Goals
2
2020
159
0.190
 Why?
Nephrologists
1
2021
12
0.180
 Why?
Male
23
2023
63512
0.180
 Why?
Critical Illness
4
2023
757
0.180
 Why?
Organism Hydration Status
1
2020
10
0.180
 Why?
Superior Vena Cava Syndrome
1
2000
3
0.180
 Why?
Chylous Ascites
1
2000
6
0.170
 Why?
Risk Factors
7
2023
9745
0.170
 Why?
Treatment Outcome
9
2020
10202
0.170
 Why?
Epidermal Growth Factor
6
1994
170
0.170
 Why?
Liver Cirrhosis
1
2003
279
0.170
 Why?
Stress, Psychological
1
2009
1066
0.170
 Why?
Acid-Base Equilibrium
1
2020
27
0.170
 Why?
Blood Volume
1
2020
60
0.170
 Why?
Aged
13
2024
22032
0.170
 Why?
Female
22
2024
68551
0.170
 Why?
Patient Care Planning
1
2020
146
0.160
 Why?
Magnesium
1
2020
153
0.160
 Why?
Potassium
1
2020
143
0.160
 Why?
Patient Reported Outcome Measures
2
2020
372
0.160
 Why?
Physician Executives
1
2019
33
0.160
 Why?
Societies, Medical
2
2020
744
0.150
 Why?
Congresses as Topic
1
2020
216
0.150
 Why?
Dogs
2
2023
382
0.150
 Why?
Survival Rate
2
2020
1869
0.150
 Why?
Drug Combinations
2
2022
330
0.150
 Why?
Receptors, Vasopressin
2
1995
19
0.140
 Why?
Kidney Concentrating Ability
1
1997
3
0.140
 Why?
Renal Insufficiency
1
2020
149
0.140
 Why?
Patient Education as Topic
3
2018
737
0.140
 Why?
Risk Assessment
4
2016
3232
0.140
 Why?
Adult
18
2024
35495
0.140
 Why?
Data Collection
1
2020
647
0.140
 Why?
Adenylyl Cyclase Inhibitors
2
1994
6
0.140
 Why?
United States
7
2023
13826
0.140
 Why?
Adenylyl Cyclases
3
1993
83
0.140
 Why?
Proportional Hazards Models
3
2022
1197
0.130
 Why?
Survival Analysis
2
2015
1269
0.130
 Why?
Hormones
2
1994
140
0.120
 Why?
Models, Animal
1
2017
376
0.120
 Why?
Ultrafiltration
1
2015
28
0.120
 Why?
Epithelial-Mesenchymal Transition
1
2017
201
0.120
 Why?
Curriculum
1
2021
910
0.120
 Why?
Sodium
2
2015
205
0.110
 Why?
Kaplan-Meier Estimate
2
2015
851
0.110
 Why?
Lung Injury
1
2017
210
0.110
 Why?
Palliative Care
1
2020
706
0.110
 Why?
Gastrointestinal Absorption
1
2014
5
0.110
 Why?
Inflammation
3
2017
2737
0.110
 Why?
Diglycerides
2
1993
61
0.110
 Why?
Virulence Factors, Bordetella
2
1991
19
0.110
 Why?
Treatment Failure
1
2015
339
0.110
 Why?
Pertussis Toxin
2
1991
26
0.110
 Why?
Biological Transport
1
2015
404
0.110
 Why?
Animals
17
2023
35309
0.110
 Why?
Didanosine
1
1993
13
0.110
 Why?
Biomedical Research
1
2020
637
0.110
 Why?
Phospholipases A
2
1992
99
0.110
 Why?
Anti-Infective Agents
1
2016
248
0.110
 Why?
Cytosol
1
1994
219
0.110
 Why?
HIV Seropositivity
1
1993
119
0.100
 Why?
Oleanolic Acid
1
2012
9
0.100
 Why?
Methylene Blue
1
2012
23
0.100
 Why?
Equipment Design
2
2014
513
0.100
 Why?
Tissue Adhesions
1
2012
30
0.100
 Why?
Vascular Calcification
1
2014
107
0.100
 Why?
Delayed Graft Function
1
2012
30
0.100
 Why?
Prognosis
4
2016
3773
0.100
 Why?
Hematinics
1
2012
20
0.100
 Why?
Cells, Cultured
9
1994
4077
0.090
 Why?
Vasoconstrictor Agents
1
2012
127
0.090
 Why?
Retrospective Studies
6
2023
14461
0.090
 Why?
Receptors, Angiotensin
1
1991
12
0.090
 Why?
Nephrectomy
1
2012
160
0.090
 Why?
Transplantation, Homologous
1
2012
400
0.090
 Why?
Atrial Natriuretic Factor
1
1991
56
0.090
 Why?
Bacterial Infections
2
2003
235
0.090
 Why?
Hypotension
1
2012
116
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1267
0.090
 Why?
Restless Legs Syndrome
1
2011
21
0.090
 Why?
Glycerides
1
1990
20
0.090
 Why?
Aluminum Compounds
1
1990
6
0.090
 Why?
Phospholipases
1
1990
13
0.090
 Why?
Antithrombins
1
2010
58
0.080
 Why?
Follow-Up Studies
4
2011
4887
0.080
 Why?
Membranes, Artificial
1
2010
70
0.080
 Why?
Models, Biological
1
2017
1722
0.080
 Why?
Virginiamycin
1
2009
3
0.080
 Why?
Linezolid
1
2009
20
0.080
 Why?
Double-Blind Method
2
2012
1875
0.080
 Why?
Daptomycin
1
2009
18
0.080
 Why?
Oxazolidinones
1
2009
14
0.080
 Why?
Graft Survival
1
2012
511
0.080
 Why?
Minerals
1
2009
39
0.080
 Why?
Acetamides
1
2009
36
0.080
 Why?
Protein Kinases
1
1991
318
0.080
 Why?
Infection Control
1
2010
140
0.080
 Why?
Enzyme Inhibitors
1
2012
827
0.080
 Why?
Antibiotic Prophylaxis
2
2022
101
0.070
 Why?
Hematuria
1
1988
12
0.070
 Why?
Communicable Diseases
1
2010
147
0.070
 Why?
Aged, 80 and over
1
2019
7055
0.070
 Why?
Sympathetic Nervous System
1
1989
174
0.070
 Why?
Hepatorenal Syndrome
1
2007
14
0.070
 Why?
RNA, Messenger
1
1995
2703
0.070
 Why?
Enzyme Activation
4
1994
812
0.070
 Why?
Sleep Wake Disorders
1
2011
251
0.070
 Why?
Kidney Tubular Necrosis, Acute
1
2007
26
0.070
 Why?
Proteinuria
1
1988
91
0.070
 Why?
Recombinant Proteins
1
2010
1304
0.070
 Why?
Tetradecanoylphorbol Acetate
3
1993
149
0.070
 Why?
Spondylitis, Ankylosing
1
1988
46
0.070
 Why?
Primary Prevention
2
2016
188
0.070
 Why?
Inositol Phosphates
3
1991
22
0.070
 Why?
ErbB Receptors
1
1990
605
0.070
 Why?
Biopsy, Needle
1
2007
189
0.060
 Why?
Anticoagulants
1
2010
636
0.060
 Why?
Incidence
3
2007
2636
0.060
 Why?
Hemodialysis Units, Hospital
1
2005
5
0.060
 Why?
Nephrology
2
2020
60
0.060
 Why?
Imipenem
1
2005
18
0.060
 Why?
Ethics, Clinical
1
2005
7
0.060
 Why?
Kinetics
3
2017
1644
0.060
 Why?
Skin Diseases
1
2007
143
0.060
 Why?
Vasculitis
1
2005
65
0.060
 Why?
Staphylococcus aureus
1
2009
434
0.060
 Why?
Capillaries
1
2005
103
0.060
 Why?
Health Services Accessibility
1
2011
899
0.060
 Why?
Medication Adherence
1
2009
556
0.060
 Why?
Canada
1
2005
350
0.060
 Why?
Fibrosis
1
2007
520
0.060
 Why?
Gastric Acid
1
2023
14
0.050
 Why?
Bromcresol Green
1
2003
1
0.050
 Why?
Bromcresol Purple
1
2003
1
0.050
 Why?
Combined Modality Therapy
1
2007
1199
0.050
 Why?
Nephelometry and Turbidimetry
1
2003
13
0.050
 Why?
Hepcidins
1
2023
22
0.050
 Why?
Disease Models, Animal
1
2014
4057
0.050
 Why?
Indicators and Reagents
1
2003
109
0.050
 Why?
Permeability
1
2003
157
0.050
 Why?
Triglycerides
1
2006
527
0.050
 Why?
Equipment Failure
1
2003
105
0.050
 Why?
Drug Resistance
2
2012
166
0.050
 Why?
Eosinophils
1
2006
324
0.050
 Why?
Vancomycin
1
2024
77
0.050
 Why?
Burns
1
2007
286
0.050
 Why?
Severity of Illness Index
2
2011
2740
0.050
 Why?
Inositol 1,4,5-Trisphosphate
2
1994
31
0.050
 Why?
Monocytes
1
2006
551
0.050
 Why?
Lung Transplantation
1
2005
289
0.050
 Why?
Regression Analysis
1
2005
991
0.050
 Why?
Medicare
2
2022
706
0.050
 Why?
Cats
1
2023
207
0.050
 Why?
Hypoalbuminemia
1
2022
30
0.050
 Why?
Cohort Studies
4
2020
5409
0.050
 Why?
Ownership
1
2023
87
0.050
 Why?
Patient Compliance
1
2006
563
0.050
 Why?
Phospholipases A2
2
1992
79
0.050
 Why?
Positron-Emission Tomography
1
2023
286
0.050
 Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
14
0.040
 Why?
Guanosine Diphosphate
2
1991
20
0.040
 Why?
Thionucleotides
2
1991
34
0.040
 Why?
Erythrocytes
1
2006
673
0.040
 Why?
Recurrence
1
2003
1005
0.040
 Why?
Dinoprostone
2
1990
187
0.040
 Why?
Chronic Disease
1
2005
1716
0.040
 Why?
Child
3
2013
20785
0.040
 Why?
Terminology as Topic
1
2020
203
0.040
 Why?
Potassium, Dietary
1
1998
11
0.040
 Why?
Drinking
1
1998
39
0.040
 Why?
Predictive Value of Tests
2
2017
1949
0.040
 Why?
Sodium, Dietary
1
1998
37
0.040
 Why?
Hyponatremia
1
1998
39
0.040
 Why?
Cardiovascular Diseases
1
2010
2003
0.040
 Why?
Diabetes Mellitus, Type 2
1
2012
2439
0.040
 Why?
Pilot Projects
1
2022
1584
0.030
 Why?
Diabetic Nephropathies
1
2000
284
0.030
 Why?
Quality Control
1
2017
163
0.030
 Why?
Hospitalization
1
2006
2052
0.030
 Why?
Dose-Response Relationship, Drug
2
1991
2011
0.030
 Why?
Fluid Therapy
1
2017
133
0.030
 Why?
Reproducibility of Results
1
2003
3080
0.030
 Why?
Prostaglandins
1
1995
93
0.030
 Why?
Quality Indicators, Health Care
1
2017
298
0.030
 Why?
Ionomycin
1
1994
25
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
181
0.030
 Why?
Isoproterenol
1
1994
115
0.030
 Why?
Prevalence
2
2011
2553
0.030
 Why?
Colforsin
1
1993
50
0.030
 Why?
Interleukin-6
1
2017
720
0.030
 Why?
Guanylate Cyclase
1
1992
35
0.030
 Why?
Shock, Surgical
1
2012
2
0.020
 Why?
Intraoperative Care
1
2012
46
0.020
 Why?
Catecholamines
1
2012
96
0.020
 Why?
Sample Size
1
2012
116
0.020
 Why?
Poisson Distribution
1
2012
73
0.020
 Why?
Prospective Payment System
1
2011
13
0.020
 Why?
Total Quality Management
1
2011
60
0.020
 Why?
Base Sequence
1
1995
2146
0.020
 Why?
Inositol
1
1991
26
0.020
 Why?
Accreditation
1
2011
80
0.020
 Why?
Receptors, Oxytocin
1
1991
23
0.020
 Why?
Cyclic GMP
1
1991
90
0.020
 Why?
Dideoxyadenosine
1
1990
1
0.020
 Why?
Oxytocin
1
1991
48
0.020
 Why?
Molecular Sequence Data
1
1995
2835
0.020
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
28
0.020
 Why?
Adenosine Diphosphate Ribose
1
1990
7
0.020
 Why?
Isoquinolines
1
1990
41
0.020
 Why?
Fluorides
1
1990
50
0.020
 Why?
Aluminum
1
1990
38
0.020
 Why?
Guanosine Triphosphate
1
1990
92
0.020
 Why?
Hydrolysis
1
1990
186
0.020
 Why?
Rats, Sprague-Dawley
1
1995
2396
0.020
 Why?
Adrenergic alpha-Agonists
1
1989
28
0.020
 Why?
Adrenergic alpha-Antagonists
1
1989
33
0.020
 Why?
Health Surveys
1
2011
493
0.020
 Why?
Analysis of Variance
1
2012
1288
0.020
 Why?
Rats, Inbred Strains
1
1989
368
0.020
 Why?
In Vitro Techniques
1
1990
1085
0.020
 Why?
Adrenergic beta-Agonists
1
1989
132
0.020
 Why?
Glomerulonephritis, IGA
1
1988
10
0.020
 Why?
Piperazines
1
1990
341
0.020
 Why?
Clinical Trials as Topic
1
2012
1004
0.020
 Why?
Cost of Illness
1
2009
277
0.020
 Why?
Adrenergic beta-Antagonists
1
1989
321
0.020
 Why?
Morbidity
1
2007
300
0.020
 Why?
Research Design
1
2012
1043
0.020
 Why?
Biomarkers
1
2017
3968
0.020
 Why?
Healthcare Disparities
1
2012
575
0.020
 Why?
Cilastatin
1
2005
2
0.020
 Why?
Hemodiafiltration
1
2005
9
0.020
 Why?
Multivariate Analysis
1
2009
1497
0.020
 Why?
Telemedicine
1
2014
788
0.010
 Why?
Osmolar Concentration
2
1998
166
0.010
 Why?
Protease Inhibitors
1
2005
106
0.010
 Why?
Sensitivity and Specificity
1
2009
1839
0.010
 Why?
Comorbidity
1
2009
1544
0.010
 Why?
Protein Kinase Inhibitors
1
1990
890
0.010
 Why?
Biopsy
1
1988
1092
0.010
 Why?
Acute Disease
1
2007
978
0.010
 Why?
Respiratory Function Tests
1
2005
583
0.010
 Why?
Drug Therapy, Combination
1
2005
1040
0.010
 Why?
Graft Rejection
1
2005
598
0.010
 Why?
Colorado
1
1990
4406
0.010
 Why?
Immunosuppressive Agents
1
2005
854
0.010
 Why?
Mice
1
2017
16915
0.010
 Why?
Lung Diseases
1
2005
739
0.010
 Why?
Beer
1
1998
7
0.010
 Why?
Diet, Vegetarian
1
1998
8
0.010
 Why?
Cross-Sectional Studies
1
2009
5050
0.010
 Why?
Urine
1
1998
60
0.010
 Why?
Dietary Proteins
1
1998
129
0.010
 Why?
Signal Transduction
1
1990
4926
0.010
 Why?
Muscarine
1
1994
3
0.010
 Why?
Carbachol
1
1994
20
0.010
 Why?
Vasopressins
1
1994
64
0.010
 Why?
Tyrosine
1
1994
223
0.010
 Why?
Cell Polarity
1
1994
139
0.010
 Why?
Purines
1
1994
172
0.010
 Why?
Adolescent
1
2012
20313
0.010
 Why?
Lung
1
2005
3927
0.010
 Why?
Hypertonic Solutions
1
1991
7
0.010
 Why?
Nocodazole
1
1991
16
0.010
 Why?
Cycloheximide
1
1991
56
0.010
 Why?
Isotonic Solutions
1
1991
37
0.010
 Why?
Culture Media
1
1991
160
0.010
 Why?
Phosphorylation
1
1994
1710
0.010
 Why?
Peptides
1
1994
923
0.000
 Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (21) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)